BCDA

BioCardia (BCDA)

BioCardia Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BCDA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/18	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2024/09/18	21 : 30	GlobeNewswire Inc.	BioCardia Regains Full Compliance with Nasdaq Listing Requirements	NASDAQ:BCDA	BioCardia Inc
2024/09/10	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2024/09/10	05 : 05	GlobeNewswire Inc.	BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules	NASDAQ:BCDA	BioCardia Inc
2024/09/07	08 : 45	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:BCDA	BioCardia Inc
2024/09/07	08 : 45	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:BCDA	BioCardia Inc
2024/09/06	01 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCDA	BioCardia Inc
2024/09/06	01 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCDA	BioCardia Inc
2024/09/06	01 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCDA	BioCardia Inc
2024/09/06	01 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCDA	BioCardia Inc
2024/09/03	19 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2024/08/31	06 : 21	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:BCDA	BioCardia Inc
2024/08/31	06 : 20	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:BCDA	BioCardia Inc
2024/08/30	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2024/08/30	21 : 00	GlobeNewswire Inc.	BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules	NASDAQ:BCDA	BioCardia Inc
2024/08/30	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BCDA	BioCardia Inc
2024/08/30	09 : 09	Edgar (US Regulatory)	Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]	NASDAQ:BCDA	BioCardia Inc
2024/08/29	21 : 30	GlobeNewswire Inc.	BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family	NASDAQ:BCDA	BioCardia Inc
2024/08/29	19 : 02	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BCDA	BioCardia Inc
2024/08/29	06 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2024/08/21	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2024/08/21	20 : 00	GlobeNewswire Inc.	FDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment	NASDAQ:BCDA	BioCardia Inc
2024/08/14	05 : 30	GlobeNewswire Inc.	BioCardia Reports Second Quarter 2024 Business Highlights and Financial Results	NASDAQ:BCDA	BioCardia Inc
2024/08/14	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2024/08/14	02 : 57	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BCDA	BioCardia Inc
2024/08/10	05 : 40	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:BCDA	BioCardia Inc
2024/08/07	20 : 00	GlobeNewswire Inc.	BioCardia to Host Q2 2024 Corporate Update and Financial Results Conference Call on August 13, 2024	NASDAQ:BCDA	BioCardia Inc
2024/08/03	06 : 01	Edgar (US Regulatory)	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities	NASDAQ:BCDA	BioCardia Inc
2024/07/30	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCDA	BioCardia Inc
2024/07/30	20 : 00	GlobeNewswire Inc.	BioCardia Submits for FDA Approval of Morph® DNA™ Steerable Introducer Product Family	NASDAQ:BCDA	BioCardia Inc